Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
The limited differences between the genomes of very different species have led to the emerging recognition that biological diversity is likely to largely derive from the complexity of RNA. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results